This report analyzes the worldwide markets for Coatings for Medical Devices in US$ Million by the following  segments: Active Coatings, Protective Coatings, Optical Coatings, and Nanotechnology Coatings. The report provides separate comprehensive analytics for North America, Europe and Rest of World.  Annual estimates and forecasts are provided for each region for the period 2006 through 2015. The report profiles 83 companies including many key and niche players such as Abbott Laboratories, Inc.,  Accord Biomaterials, Inc., AdvanSource Biomaterials Corp, AeonClad Coatings LLC, Affinergy, Inc., Allvivo Vascular, Inc., Angiotech Pharmaceuticals, Inc., Armoloy of Connecticut, Inc., AST Products, Inc., Bacterin International Inc., Biocoat, Inc., Biophan Technologies, Inc.,  Carmeda AB, Ceragenix Pharmaceuticals Inc., Covalon Technologies Ltd., Hemoteq AG, Hydromer, Inc., I-Flow Corp., Implant Sciences Corp, MIV Therapeutics, Inc., Nerites Corp., Nanocopoeia, Inc., NUCRYST Pharmaceuticals Corp., Specialty Coating Systems, Inc., Spire Corp, and SurModics, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

TABLE OF CONTENTS

COATINGS FOR MEDICAL DEVICES							MCP-1769
A GLOBAL STRATEGIC BUSINESS REPORT


                                         CONTENTS

  I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

      Study Reliability and Reporting Limitations                       I-1
      Disclaimers                                                       I-2
      Data Interpretation & Reporting Level                             I-3
       Quantitative Techniques & Analytics                              I-3
      Product Definitions and Scope of Study                            I-3
       Active Coatings                                                  I-3
       Protective Coatings                                              I-4
       Optical Coatings                                                 I-4
       Nanotechnology Coatings                                          I-4


 II. EXECUTIVE SUMMARY

  1. GLOBAL MARKET OVERVIEW                                             II-1
      Medical Devices - A Global Insight                                II-1
      US Leads the Medical Devices Market                               II-1
       Table 1: Worldwide Medical Devices Market by Geographic
       Region: Percentage Breakdown of Value Sales for United
       States, Europe, Japan and Rest of World (includes
       corresponding Graph/Chart)                                       II-1

       Table 2: European Medical Device Market by Geographic Region:
       Percentage Breakdown of Production for ermany, France, UK,
       Italy and Rest of Europe (includes corresponding Graph/Chart)    II-2
      Coatings - An Indispensable Role to Play in Medical Devices       II-2
      Making Extraordinary Contribution to Ordinary Medical Devices     II-2
      Cooling the Issue of Bacterial Growth & Contamination             II-3
      Combating Biofilms and Hospital Acquired Infections with
       Coated Medical Devices                                           II-3
      Coatings Redefine the Functionality of Medical Devices            II-4
      Advanced Coatings on Medical Implants                             II-4
      Coating Medical Devices - A Powerful Approach to Control
       Restenosis                                                       II-4
      Multi-functional Coating - A One-for-All Approach Against
       Device Induced Infection                                         II-5
      Advanced Coatings - Enhancing Lifespan of Implants                II-5
      Lubricious Coatings - Imparting Multiple Properties to Medical
       Devices                                                          II-6
      Aqueous-based Coatings Win Over Solvent-based                     II-6
      Drug-Eluting Stent Coatings - A Breakthrough Biologic             II-7
       Cell Signaling DES Coatings                                      II-7
       Biodegradable DES Coatings                                       II-7
       United States - The Largest Market for Drug-Eluting Stents       II-7
      New Approaches to Tackle Biofilm Formation Head On                II-8
      Medical Companies Weighing Up the Silver Technology               II-8
      Cardiology - A High Potential End-Use Market                      II-9
      Current and Future Analysis                                       II-9
       The Current Perspective                                          II-10
       Market Drivers                                                   II-10
        Developing Economies                                            II-10
        Rise in Aging Population                                        II-11
        Increasing Life Expectancy Rates                                II-11
        Rise in Incidence of Joint Diseases                             II-12
         Table 3: Select Musculoskeletal Conditions - Percentage
         Breakdown by Age Group (includes corresponding Graph/Chart)    II-12
        Rise in Joint Replacement Surgeries                             II-12
        Increasing Life Expectancy Improves Rates of Revision
         Procedures                                                     II-13
        Rise in Hospital-Acquired Infections                            II-13
       Drug-Eluting Stents Transform the Scenario of Interventional
        Cardiology                                                      II-13
       The Future Perspective                                           II-13

  2. MARKET TRENDS AND ISSUES                                           II-15
      Contamination of Intravenous Equipment: A Weighty Issue           II-15
      Staggering Number of Hospital Acquired Infections Ring Alarm      II-15
      The Battle Against Microbes Continues                             II-16
      Lack of Awareness - An Impasse for Fast Uptake of
       Antimicrobial Coated Catheters                                   II-16
      Nanotechnology Potential in Coating Yet Unexplored                II-16
       Nanomaterials Applications in Medical Devices                    II-16
      Smart Coatings                                                    II-17
      Suboptimal Coatings - A Prime Concern                             II-18
      High Price - A Major Impediment to DES Growth                     II-18
      Adverse Effects, Product Limitations Restrict Des Market Growth   II-18

  3. PRODUCT OVERVIEW                                                   II-20
      Coating for Medical Devices - Expanding Beyond Boundaries         II-20
      Medical Device Coatings - By Platform                             II-20
       Active Coatings                                                  II-20
       Optical Coatings                                                 II-20
       Protective Coatings                                              II-21
       Nano-based Coatings                                              II-21
      Coating and Surface Treatment Technologies                        II-21
       Surface Adsorption                                               II-21
       Drug Sequestering                                                II-22
       Ion Beam Assisted Deposition                                     II-22
       Ion Implantation                                                 II-22
       Physical Vapor Deposition                                        II-23
       Plasma Surface Modification                                      II-23
        Plasma Surface Modification Technology Applications by
         Medical Speciality                                             II-24
       Ultraviolet Curing                                               II-24
      Issues Associated with Coating Technologies                       II-25
      Medical Device Coating Materials                                  II-25
       Aluminum                                                         II-25
       Aluminum Fluoride                                                II-25
       Diamond Coatings                                                 II-26
       Parylene Coating                                                 II-26
        Parylene HT                                                     II-26
         Parylene HT Applications                                       II-27
       Silver                                                           II-27
        Silver Coating Technique                                        II-28
       Silicone                                                         II-28
       Titanium Dioxide                                                 II-28
       TiN                                                              II-29

  4. LEADING DRUG-ELUTING STENTS MARKET                                 II-30
      Big Names Corner Big Share in DES Market                          II-30
       DES Product Launches by Major Manufacturers between 2002 and
        2007                                                            II-30
       Cypher Leads the Drug-Eluting Stents Market                      II-30
       TAXUS' the Leader in the Largest Stents Market, the US           II-31

  5. PRODUCT INNOVATIONS/INTRODUCTIONS/ APPROVALS                       II-32
      Nucryst Pharmaceuticals Introduces Acticoat(TM) Flex7 and Flex3      II-32
      Nucryst Receives FDA Marketing Clearance for Acticoat(TM) Flex       II-32
      EFD Rolls Out New Aseptic Spray Valve                             II-32
      Boston Scientific Wins FDA Approval for Second-generation
       Drug-Coated Stent                                                II-33
      Abbott Obtains FDA Approval for XIENCE V(TM)                         II-33
      Lombard Medical Develops New Catheter Coating                     II-33
      Ecology Coatings to Launch EcoQuick Product Line                  II-33
      Bayer MaterialScience to Develop Hydrophilic PU Coatings          II-33
      Ceragenix Announces Pre-clinical Outcome of CeraShield Coated
       Tubes                                                            II-34
      Ceragenix Pharmaceuticals Introduces New Coating Compound         II-34
      Sono-Tek Rolls Out MediCoat PSI                                   II-34
      C.R. Bard Obtains FDA Clearance for Agento Endotracheal Tube      II-34
      Boston Scientific Wins Japanese Approval for TAXUS(R) Express2(TM)
       Stent System                                                     II-34
      EFD Releases New Adhesive Coating System, Relius(TM)                 II-35
      Arkansas Researchers Develop Nanowires Coating for Titanium
       Implants                                                         II-35
      Micell Develops Coating Technology for Safe and Effective
       Medical Devices                                                  II-35

  6. RECENT INDUSTRY ACTIVITY                                           II-36
      Biocoat Inks Agreement with Agion Technologies                    II-36
      AST Products and Keller Medical Ink Agreement                     II-36
      Nobel Biocare and Ceragenix Pharmaceuticals Sign Agreement        II-36
      MAST BioSurgery Inks Agreement with Ceragenix Pharmaceuticals     II-36
      AeonClad Coatings Establishes AeonClad Biomedical                 II-37
      Hydromer Divests Business to Forefront Medical Technologies       II-37
      Lombard Medical to Divest Polymer Coatings Business               II-37
      Berwind Acquires Specialty Coating Systems                        II-37
      DSM Acquires The Polymer Technology Group                         II-38
      Curtiss-Wright Acquires Parylene Coating                          II-38
      Wright Medical Group Acquires INBONE Technologies                 II-38
      Biophan Acquires Nanoset's Patent Portfolio                       II-39
      AdvanSource, the New Corporate Identity of CardioTech             II-39
      CardioTech Divest Subsidiary to TACPRO                            II-39
      CardioTech Sells Gish Biomedical                                  II-39
      Covalon Technologies Signs Agreement for Antimicrobial Coating    II-39
      Nanocopoeia Inks Licensing Agreement with WORLDiscoveries(TM)        II-39
      Carestream Health Forms Tollcoating.com                           II-40
      Nerites Receives SBIR Grant for Polymer Coating                   II-40
      Affinergy Receives SBIR Grant for Polymer Coating                 II-40
      HnG Medical and Hydromer Ink Agreement                            II-40
      David Lu Signs Agreement with Hydromer                            II-41
      SurModics Enters into Partnership with Elixir Medical             II-41
      Specialty Coating Announces Parylene Japan Acquisition            II-41
      MIV Therapeutics Announces Acquisition of Biosync Scientific      II-41
      Greatbatch Acquires Biomec Assets                                 II-42
      DSM Venturing Acquires Stake in Harland Medical Systems           II-42
      SurModics Collaborates with OakRiver Technology                   II-42
      Hydromer and Allium Announce Coating Services Agreement           II-42
      Lombard Medical Receives Financial Assistance from Yorkshire
       Forward                                                          II-42
      Kane Biotech Signs Agreement with Harland Medical Systems         II-43
      SurModics and Paragon Collaborate to Develop New Stent System     II-43
      AST Products Enters into a Licensing Deal with EKOS               II-43
      AST Products Joins Hands with Percutaneous Systems                II-43
      AST Products and LeMaitre Vascular Sign Licensing Deal            II-44

  7. FOCUS ON SELECT GLOBAL PLAYERS                                     II-45
      Abbott Laboratories, Inc. (US)                                    II-45
      Accord Biomaterials, Inc. (US)                                    II-45
      AdvanSource Biomaterials Corp. (US)                               II-45
      AeonClad Coatings LLC (US)                                        II-46
      Affinergy, Inc. (US)                                              II-46
      Allvivo Vascular, Inc. (US)                                       II-46
      Angiotech Pharmaceuticals, Inc. (Canada)                          II-46
      Armoloy of Connecticut, Inc. (US)                                 II-47
      AST Products, Inc. (US)                                           II-47
      Bacterin International Inc. (US)                                  II-48
      Biocoat, Inc. (US)                                                II-48
      Biophan Technologies, Inc. (US)                                   II-48
      Carmeda AB (Sweden)                                               II-49
      Ceragenix Pharmaceuticals Inc. (US)                               II-49
      Covalon Technologies Ltd. (Canada)                                II-49
      Hemoteq AG (Germany)                                              II-50
      Hydromer, Inc. (US)                                               II-50
      I-Flow Corp. (US)                                                 II-50
      Implant Sciences Corp. (US)                                       II-51
      MIV Therapeutics, Inc. (Canada)                                   II-51
      Nerites Corp. (US)                                                II-51
      Nanocopoeia, Inc. (US)                                            II-51
      NUCRYST Pharmaceuticals Corp. (US)                                II-52
      Specialty Coating Systems, Inc. (US)                              II-52
      Spire Corp. (US)                                                  II-52
      SurModics, Inc. (US)                                              II-53

  8. GLOBAL MARKET PERSPECTIVE                                          II-54
      Table 4: World Recent Past, Current and Future Analysis for
      Medical Device Coatings* by Geographic Region/Country - North
      America, Europe and Rest of World Markets Independently
      Analyzed with Annual Sales Figures in US$ Million for Years
      2006 through 2015 (includes corresponding Graph/Chart)            II-54

      Table 5: World 10-Year Perspective for Medical Device
      Coatings* by Geographic Region/Country - Percentage Breakdown
      of Dollar Sales for North America, Europe and Rest of World
      Markets for Years 2006, 2009 & 2015 (includes corresponding
      Graph/Chart)                                                      II-55

      Table 6: World Recent Past, Current and Future Analysis for
      Active Coatings in Medical Devices by Geographic
      Region/Country - North America, Europe and Rest of World
      Markets Independently Analyzed with Annual Sales Figures in
      US$ Million for Years 2006 through 2015 (includes
      corresponding Graph/Chart)                                        II-56

      Table 7: World 10-Year Perspective for Active Coatings in
      Medical Devices by Geographic Region/Country - Percentage
      Breakdown of Dollar Sales for North America, Europe and Rest
      of World Markets for Years 2006, 2009 & 2015 (includes
      corresponding Graph/Chart)                                        II-57

      Table 8: World Recent Past, Current and Future Analysis for
      Protective Coatings in Medical Devices by Geographic
      Region/Country - North America, Europe and Rest of World
      Markets Independently Analyzed with Annual Sales Figures in
      US$ Million for Years 2006 through 2015 (includes
      corresponding Graph/Chart)                                        II-58

      Table 9: World 10-Year Perspective for Protective Coatings in
      Medical Devices by Geographic Region/Country - Percentage
      Breakdown of Dollar Sales for North America, Europe and Rest
      of World Markets for Years 2006, 2009 & 2015 (includes
      corresponding Graph/Chart)                                        II-59

      Table 10: World Recent Past, Current and Future Analysis for
      Optical Coatings in Medical Devices by Geographic
      Region/Country - North America, Europe and Rest of World
      Markets Independently Analyzed with Annual Sales Figures in
      US$ Million for Years 2006 through 2015 (includes
      corresponding Graph/Chart)                                        II-60

      Table 11: World 10-Year Perspective for Optical Coatings in
      Medical Devices by Geographic Region/Country - Percentage
      Breakdown of Dollar Sales for North America, Europe and Rest
      of World Markets for Years 2006, 2009 & 2015 (includes
      corresponding Graph/Chart)                                        II-61

      Table 12: World Recent Past, Current and Future Analysis for
      Nanotechnology Coatings in Medical Devices by Geographic
      Region/Country - North America, Europe and Rest of World
      Markets Independently Analyzed with Annual Sales Figures in
      US$ Million for Years 2009 through 2015 (includes
      corresponding Graph/Chart)                                        II-62

      Table 13: World 7-Year Perspective for Nanotechnology Coatings
      in Medical Devices by Geographic Region/Country - Percentage
      Breakdown of Dollar Sales for North America, Europe and Rest
      of World Markets for Years 2010 & 2015 (includes corresponding
      Graph/Chart)                                                      II-63


III. MARKET

  1. NORTH AMERICA                                                      III-1
      A.Market Analysis                                                 III-1
        Current and Future Analysis                                     III-1
        The United States Outlook                                       III-1
         Hospital-Acquired Infections - A Serious Concern in the US     III-1
         Drug Eluting Stents Growth Faces Roadblock                     III-1
          DES Product Launches by Major Manufacturers between 2003
           and 2007                                                     III-2
         Aging Population, Obesity Drive Demand for Orthopedic Implants III-2
          Table 14: Primary Hip and Knee Replacement Procedures in
          the US - Percentage Breakdown by Age Group (includes
          corresponding Graph/Chart)                                    III-2

          Table 15: US Population - Percentage Proportion of
          Population by Age Group (includes corresponding
          Graph/Chart)                                                  III-3
         Rising Incidence of Arthritis Aids Growth in Implant
          Procedures                                                    III-3
          Table 16: Knee Replacements in the US (1998-2008): Number
          of Procedures (in Thousands) (includes corresponding
          Graph/Chart)                                                  III-4

          Table 17: Hip Replacements in the US (1998-2005): Number
          of Procedures (in Thousands) (includes corresponding
          Graph/Chart)                                                  III-4
         Medicare Curtails Reimbursement for Hospital- acquired
          Nosocomial Infections                                         III-5
        The Canadian Outlook                                            III-5
         Aging Population, Arthritis Fuel Demand for Knee Implants      III-5
        Product Innovations/Introductions/Approvals                     III-5
        Strategic Corporate Developments                                III-8
        Key Players                                                     III-16
      B.Market Analytics                                                III-24
        Table 18: North American Recent Past, Current and Future
        Analysis for Medical Device Coatings by Type - Active,
        Protective, Optical and Nanotechnology Coating Platforms
        Independently Analyzed with Annual Sales Figures in US$
        Million for Years 2006 through 2015 (includes corresponding
        Graph/Chart)                                                    III-24

        Table 19: North American 10-Year Perspective for Medical
        Device Coatings by Type - Percentage Breakdown of Dollar
        Sales for Active, Protective, Optical and Nanotechnology
        Markets for Years 2006, 2009 & 2015 (includes corresponding
        Graph/Chart)                                                    III-25

  2. EUROPE                                                             III-26
      A.Market Analysis                                                 III-26
        Current and Future Analysis                                     III-26
        Product Innovations/Introductions/Approvals                     III-26
        Strategic Corporate Developments                                III-27
        Key Players                                                     III-27
      B.Market Analytics                                                III-28
        Table 20: European Recent Past, Current and Future Analysis
        for Medical Device Coatings by Type - Active, Protective,
        Optical and Nanotechnology Markets Independently Analyzed
        with Annual Sales Figures in US$ Million for Years 2006
        through 2015 (includes corresponding Graph/Chart)               III-28

        Table 21: European 10-Year Perspective for Medical Device
        Coatings by Type - Percentage Breakdown of Dollar Sales for
        Active, Protective, Optical and Nanotechnology Markets for
        Years 2006, 2009 & 2015 (includes corresponding Graph/Chart)    III-29

  3. REST OF WORLD                                                      III-30
      A.Market Analysis                                                 III-30
        Current and Future Analysis                                     III-30
        Strategic Corporate Developments                                III-30
      B.Market Analytics                                                III-32
        Table 22: Rest of World Recent Past, Current and Future
        Analysis for Medical Device Coatings by Type - Active,
        Protective, Optical and Nanotechnology Markets Independently
        Analyzed with Annual Sales Figures in US$ Million for Years
        2006 through 2015 (includes corresponding Graph/Chart)          III-32

        Table 23: Rest of World 10-Year Perspective for Medical
        Device Coatings by Type - Percentage Breakdown of Dollar
        Sales for Active, Protective, Optical and Nanotechnology
        Markets for Years 2006, 2009 & 2015 (includes corresponding
        Graph/Chart)                                                    III-33


 IV. COMPETITIVE LANDSCAPE

     Total Companies Profiled: 83 (including Divisions/Subsidiaries - 86)

     ------------------------------------------
     Region/Country                     Players
     ------------------------------------------
     The United States                    69
     Canada                                5
     Europe                               11
      Germany                              2
      The United Kingdom                   5
      Rest of Europe                       4
     Asia-Pacific (Excluding Japan)        1
     ------------------------------------------